Helperby Therapeutics (Helperby) is a biopharmaceutical company dedicated to developing the next generation of lifesaving antibiotics.

Existing antibiotic treatments are rapidly becoming obsolete. Doctors increasingly rely on last resort antibiotics such as carbapenems and colistin. As harmful bacteria continue to mutate, this final line of resistance will eventually fail.

Helperby’s unique antibiotic technology outsmarts highly resistant bacteria by combining new resistance breakers with old antibiotics to create a whole new generation of therapies. This new lease of life for antibiotics will help to sustain our defence against life threatening superbugs for years to come.

The Company was spun out of St George‘s, University of London in 2002.